Pelican Therapeutics' Unattributed Round

Pelican Therapeutics raised a round of funding on June 09, 2014.

Pelican Therapeutics is developing biologic agents that represent the next generation of TNF based immunotherapy. TNFRSF25 agonists provide a CD8+ T cell and Th1-type antibody adjuvant signal when use…

Articles about Pelican Therapeutics' Unattributed Round: